Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |